Literature DB >> 18509066

Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor.

Christophe D Proulx1, Brian J Holleran, Antony A Boucard, Emanuel Escher, Gaétan Guillemette, Richard Leduc.   

Abstract

Class A (rhodopsin-like) G protein-coupled receptors possess conserved residues and motifs that are important for their specific activity. In the present study, we examined the role of residue Asp97(2.50) as well as residues Glu147(3.49), Arg148(3.50), and Tyr149(3.51) of the ERY motif on the functionality of the urotensin II receptor (UT). Mutations D97(2.50)A, R148(3.50)A, and R148(3.50)H abolished the ability of UT to activate phospholipase C, whereas mutations E147(3.49)A and Y149(3.51)A reduced the ability to activate PLC by 50%. None of the mutants exhibited constitutive activity. However, R148(3.50)A and R148(3.50)H promoted ERK1/2 activation, which was abolished by 4-(3-chloroanilino)-6,7-dimethoxyquinazoline (AG1478), an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase activity. Both these mutants were capable of directly activating EGFR, which confirmed that they activated the mitogen-activated protein kinase (MAPK) pathway by a Galpha(q/11)-independent transactivation of EGFR. The D97(2.50)A, R148(3.50)A, and R148(3.50)H mutants did not readily internalize and did not promote translocation or colocalize with beta-arrestin2-GFP. Finally, the agonist-induced internalization of the E147(3.49)A mutant receptor was significantly increased compared with wild-type receptor. This study highlights the major contribution of the conserved Asp(2.50) residue to the functionality of the UT receptor. The Arg residue in the ERY motif of UT is an important structural element in signaling crossroads that determine whether Galpha(q/11)-dependent and -independent events can occur.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18509066     DOI: 10.1124/mol.108.045054

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  14 in total

1.  Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.

Authors:  Ross M Potter; Kaleeckal G Harikumar; S Vincent Wu; Laurence J Miller
Journal:  J Lipid Res       Date:  2011-10-21       Impact factor: 5.922

Review 2.  GPCR activation: protonation and membrane potential.

Authors:  Xuejun C Zhang; Kening Sun; Laixing Zhang; Xuemei Li; Can Cao
Journal:  Protein Cell       Date:  2013-09-20       Impact factor: 14.870

3.  Structural basis of activation of bitter taste receptor T2R1 and comparison with Class A G-protein-coupled receptors (GPCRs).

Authors:  Nisha Singh; Sai Prasad Pydi; Jasbir Upadhyaya; Prashen Chelikani
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

4.  Allosteric sodium in class A GPCR signaling.

Authors:  Vsevolod Katritch; Gustavo Fenalti; Enrique E Abola; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Biochem Sci       Date:  2014-04-21       Impact factor: 13.807

5.  Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma.

Authors:  C Lecointre; L Desrues; J E Joubert; N Perzo; P-O Guichet; V Le Joncour; C Brulé; M Chabbert; R Leduc; L Prézeau; A Laquerrière; F Proust; P Gandolfo; F Morin; H Castel
Journal:  Oncogene       Date:  2015-01-19       Impact factor: 9.867

6.  The role of a sodium ion binding site in the allosteric modulation of the A(2A) adenosine G protein-coupled receptor.

Authors:  Hugo Gutiérrez-de-Terán; Arnault Massink; David Rodríguez; Wei Liu; Gye Won Han; Jeremiah S Joseph; Ilia Katritch; Laura H Heitman; Lizi Xia; Adriaan P Ijzerman; Vadim Cherezov; Vsevolod Katritch; Raymond C Stevens
Journal:  Structure       Date:  2013-11-07       Impact factor: 5.006

7.  The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation.

Authors:  Ivana Domazet; Brian J Holleran; Stéphane S Martin; Pierre Lavigne; Richard Leduc; Emanuel Escher; Gaétan Guillemette
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

8.  A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment.

Authors:  Aditya J Desai; Kaleeckal G Harikumar; Laurence J Miller
Journal:  J Biol Chem       Date:  2014-05-13       Impact factor: 5.157

9.  Sensitivity of cholecystokinin receptors to membrane cholesterol content.

Authors:  Aditya J Desai; Laurence J Miller
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-18       Impact factor: 5.555

10.  The 2.1 Å resolution structure of cyanopindolol-bound β1-adrenoceptor identifies an intramembrane Na+ ion that stabilises the ligand-free receptor.

Authors:  Jennifer L Miller-Gallacher; Rony Nehmé; Tony Warne; Patricia C Edwards; Gebhard F X Schertler; Andrew G W Leslie; Christopher G Tate
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.